0000950170-24-018047.txt : 20240221 0000950170-24-018047.hdr.sgml : 20240221 20240221170122 ACCESSION NUMBER: 0000950170-24-018047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khayal Tamer I CENTRAL INDEX KEY: 0001430462 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 24660730 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-02-16 0001756262 TransMedics Group, Inc. TMDX 0001430462 Khayal Tamer I C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 false true false false Chief Commercial Officer true Common Stock 2024-02-16 4 M false 1144 16.00 A 15519 D Common Stock 2024-02-16 4 M false 1714 16.14 A 17233 D Common Stock 2024-02-16 4 S false 2858 90.00 D 14375 D Common Stock 2024-02-20 4 M false 250 16.14 A 14625 D Common Stock 2024-02-20 4 S false 250 90.00 D 14375 D Common Stock 14776 I By the Khayal Family 2021 Irrevocable Trust Common Stock 11051 I By the Tamer Ibrahim Ahmed Khayal Trust Stock Option (Right to Buy) 16.00 2024-02-16 4 M false 1144 0.00 D 2029-05-01 Common Stock 1144 0 D Stock Option (Right to Buy) 16.14 2024-02-16 4 M false 1714 0.00 D 2030-02-27 Common Stock 1714 15996 D Stock Option (Right to Buy) 16.14 2024-02-20 4 M false 250 0.00 D 2030-02-27 Common Stock 250 15746 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The option is fully vested. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-02-21